Profil
Eric Tansky is currently a General Partner at Accelmed Ventures.
Prior to his current position, he worked as a Director at TearLab Corporation, Inc.
Postes actifs de Eric Tansky
| Sociétés | Poste | Début |
|---|---|---|
Accelmed Ventures
 Accelmed Ventures Investment ManagersFinance Accelmed Ventures provides pharmaceutical and biotech technology services. The company was founded by Mori Arkin in 2009 and is headquartered in Miami, Florida. | Private Equity Investor | - |
Anciens postes connus de Eric Tansky
| Sociétés | Poste | Fin |
|---|---|---|
| TEARLAB CORPORATION | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Accelmed Ventures
Accelmed Ventures Investment ManagersFinance Accelmed Ventures provides pharmaceutical and biotech technology services. The company was founded by Mori Arkin in 2009 and is headquartered in Miami, Florida. | Finance |
TearLab Corporation, Inc.
 TearLab Corporation, Inc. Medical SpecialtiesHealth Technology TearLab Corporation, Inc. engages in the development and marketing of a tear testing platform. Its primary product, the TearLab Osmolarity System, enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. It measures tear film osmolarity for the diagnosis of dry eye disease. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in Southlake, TX. | Health Technology |
